Brunswick Corporation logo

Brunswick Corporation

BC | NYSE
Chart Builder DCF Calculator
$75.34
+$0.98 (+1.32%)
At close: Oct 30, 2026, 4:00 PM ET
$75.34
$0.00 (0.00%)
Pre-market: Nov 2, 2026, 8:23 AM ET
+1.32%

No price chart data available for 1D timeframe.

Rating

Updated: Nov 2, 2026
42.3
+11.1 pts
Fundamentals Average
Market Sentiment Neutral
Moat Narrow
Sector Rank #360/608 (Top 59%)

Key Statistics

Market Data

Market Cap $4.88B
1D Range
73.37 75.95
52W Range
59.34 89.22

Valuation (TTM)

PE 23.33
PB 2.89
EV/EBITDA 10.38

Valuation (NTM)

Forward PE 13.96
Forward PEG 0.59
Price Target $81.40
Loading financial charts...

Profile

Brunswick Corporation designs, manufactures, and markets recreation products in the United States, Europe, the Asia-Pacific, Canada, and internationally. The company operates through four segments: Pr...

Employees 14,000
IPO Date Dec 31, 1981
Fiscal Year January - December

Latest News

Brunswick Q3 Earnings Call Highlights

3 days ago · marketbeat.com

Brunswick Q3 Earnings Call Highlights
Brunswick Corporation (BC) Q3 2026 Earnings Call Transcript

3 days ago · seekingalpha.com

Brunswick Corporation (BC) Q3 2026 Earnings Call Transcript
Brunswick (BC) Q3 Earnings: Taking a Look at Key Metrics Versus Estimates

4 days ago · zacks.com

Brunswick (BC) Q3 Earnings: Taking a Look at Key Metrics Versus Estimates
Brunswick (BC) Tops Q3 Earnings and Revenue Estimates

4 days ago · zacks.com

Brunswick (BC) Tops Q3 Earnings and Revenue Estimates
Brunswick Corporation Releases 2026 Third Quarter Earnings

4 days ago · globenewswire.com

Brunswick Corporation Releases 2026 Third Quarter Earnings
Nexcel Metals Mobilizes Diamond Drill to Burnt Hill Tungsten Project, New Brunswick, Following Exploration Licence Agreement

6 days ago · newsfilecorp.com

Nexcel Metals Mobilizes Diamond Drill to Burnt Hill Tungsten Project, New Brunswick, Following Exploration Licence Agreement
Hengrui Pharma Previews ESMO Congress 2026: 64 Research Findings Highlight Continued Progress Across Innovative Pipelines to Advance Clinical Value

13 days ago · gurufocus.com

Hengrui Pharma Previews ESMO Congress 2026: 64 Research Findings Highlight Continued Progress Across Innovative Pipelines to Advance Clinical Value
Brunswick Corporation Declares Quarterly Dividend

14 days ago · globenewswire.com

Brunswick Corporation Declares Quarterly Dividend
A.I.S. Resources Sponsors PhD Research to Advance Geological Exploration at St. John Project

14 days ago · globenewswire.com

A.I.S. Resources Sponsors PhD Research to Advance Geological Exploration at St. John Project
Brunswick Keeps Navigating Tough Waters (Rating Upgrade)

15 days ago · seekingalpha.com

Brunswick Keeps Navigating Tough Waters (Rating Upgrade)

Earnings

Latest Earnings
Oct 29, 2026
EPS
$1.58
Beat +17.04%
REV
$1.45B
Miss -0.09%
Next Earnings
Jan 28, 2027
EPS Est
Pro
Rev Est
Pro
Earnings Details ➞

Analyst Summary

# of Analysts
10
Consensus
Buy
Price Target
$81.00
Upside
+7.51%
Buy (5)
Hold (4)
Sell (0)
Analyst Details ➞

© 2026 bestshares.com. All rights reserved.

All data is for informational purposes only. bestshares.com is not a broker, dealer, or registered investment adviser, and nothing on this site is a recommendation to buy or sell any security.